Chandra Vargeese, Chief Technology Officer at Wave Life Sciences Ltd. (WVE), sold 3,145 shares at $10.57 ($33K) on 2021-02-16, disclosed to the SEC on 2021-02-18.
Scheduled sale ($33k) by Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| WVE | SELL | 2022-05-06 | $29K | — | Filing → |
| WVE | SELL | 2022-02-18 | $25K | — | Filing → |
| WVE | SELL | 2020-02-20 | $25K | — | Filing → |